N/A
Completed N=8
Social Work Assistance and Stipends for Housing (SASH)
Opioid-Related Disorders · Housing Problems
Source: ClinicalTrials.gov NCT05803603 ↗
Enrolled (actual)
8
Serious AEs
0.0%
Results posted
Apr 2025
Primary outcomePrimary: Methadone Doses — 4.58 percent of missed doses
Summary
SASH is a clinical trial feasibility study that will provide an intervention to improve Opioid Use Disorder (OUD), Quality of Life (QOL), and housing outcomes for homeless patients receiving Medication for Opiate Use Disorder (MOUD). The main questions of the study are does a $500 housing stipend for individuals on MOUD increase treatment retention, improved quality of life and prevent homelessness.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Methadone Doses |
34.11 | — |
| PRIMARY OUD Checklist Scores |
7.2 | — |
| PRIMARY Urine Toxicology Tests |
3 | — |
| PRIMARY Quality of Life Scores |
32 | — |
| PRIMARY Housed vs Unhoused at 6 Months |
3 | .125 |
Eligibility Criteria
Inclusion Criteria
- Experienced homelessness during at least 15 of the 30 days preceding enrollment
- Is a patient at the University of Maryland Addiction Treatment Program (ATP) receiving methadone treatment.
Exclusion Criteria
-
Data sourced from ClinicalTrials.gov (NCT05803603). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.